Barclays PLC Medpace Holdings, Inc. Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 31,140 shares of MEDP stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,140
Previous 27,418
13.58%
Holding current value
$11.9 Million
Previous $8.4 Million
49.75%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding MEDP
# of Institutions
632Shares Held
25.4MCall Options Held
154KPut Options Held
117K-
Vanguard Group Inc Valley Forge, PA2.5MShares$956 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.49MShares$952 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT974KShares$372 Million2.07% of portfolio
-
Invesco Ltd. Atlanta, GA816KShares$312 Million0.07% of portfolio
-
State Street Corp Boston, MA697KShares$266 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $11.9B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...